CRISPR Therapeutics AG - Stock Price History | CRSP

Historical daily share price chart and data for CRISPR Therapeutics AG since 2021 adjusted for splits. The latest closing stock price for CRISPR Therapeutics AG as of September 27, 2021 is 117.26.
  • The all-time high CRISPR Therapeutics AG stock closing price was 210.04 on January 14, 2021.
  • The CRISPR Therapeutics AG 52-week high stock price is 220.20, which is 87.8% above the current share price.
  • The CRISPR Therapeutics AG 52-week low stock price is 79.31, which is 32.4% below the current share price.
  • The average CRISPR Therapeutics AG stock price for the last 52 weeks is 128.90.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
CRISPR Therapeutics AG Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 79.5528 59.3200 173.2300 33.6800 153.1100 151.39%
2019 44.3630 29.8700 73.1300 28.0200 60.9050 113.18%
2018 46.4268 25.1700 73.5900 22.7300 28.5700 21.68%
2017 18.3163 22.5000 23.7300 13.6200 23.4800 15.89%
2016 18.6885 14.0900 23.0700 13.8200 20.2600 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $8.935B $0.001B
CRISPR Therapeutics AG is a gene-editing company. It focused on the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 gene-editing platform. CRISPR Therapeutics AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $132.971B 8.85
Bio-Rad Laboratories (BIO.B) United States $22.624B 48.22
QIAGEN (QGEN) Netherlands $12.001B 20.32
Biohaven Pharmaceutical Holding (BHVN) United States $8.691B 0.00
Emergent Biosolutions (EBS) United States $2.870B 6.92
Arcus Biosciences (RCUS) United States $2.690B 0.00
Myovant Sciences (MYOV) United Kingdom $2.182B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.045B 0.00
Zymeworks (ZYME) Canada $1.373B 0.00
Ambrx Biopharma (AMAM) United States $0.501B 0.00
SQZ Biotechnologies (SQZ) United States $0.442B 0.00
Enzo Biochem (ENZ) United States $0.174B 51.29